Gross Profit improved from 22% to 29% over the previous year's corresponding 3-month period.
Revenues increased by US$1.4 million or 16.1% over the corresponding previous year 9-month period.
Gross profit improved from 22.8% to 27% compared with the 9-month period of the prior year.
VANCOUVER, BC, Dec. 1, 2025 /PRNewswire/ - Eshbal Functional Food Inc. (TSXV: ESBL) ("Eshbal" or the "Company"), a developer of gluten-free and health-focused food products, reported its consolidated financial results for the three- and nine-month periods ended September 30, 2025, The financial statements and MD&A are available on SEDAR under the Company's profile.
The following disclosure does not constitute full disclosure of the Company's financial and operational condition and is qualified by, and should be read in conjunction with, the Company's Management Discussion and Analysis for the period ending Sep 30, 2025 and corresponding financial statements available at sedarplus.ca
2025 Third Quarter Financial ResultsAll figures are in U.S. Dollars unless otherwise indicated.
Strong revenue growth, significant margin expansion, and continued progress toward North American market entry
Revenue and Gross Margin:
For the third quarter, the three months ended September 30, 2025, the Company reported revenues of US$3.38 million, an increase of US$673 thousand, a 25% increase compared to US$2.7 million in the corresponding prior-year period. Gross profit improved to US$995 thousand (29% of revenues), compared to US$596 thousand (22% of revenues) in Q3, 2024.
For the nine months ended September 30, 2025, the Company reported revenues of US$10.1 million, an increase of US$1.4 million, a 16% increase compared to US$8.7 million in the corresponding prior-year period. Gross profit improved to US$2.7 million (27% of revenues), compared to US$2 million (22.8% of revenues) in the corresponding prior-year period.
For the nine months ended September 30, 2025, the Company reported EBITDA of US$679 thousand.
Operating and Net Profit:
Operating income for the nine-month period ended September 30, 2025 was US$127 thousand, remaining positive despite new public company ...
